Drug Shortage Report for GALLIUM (GA67) CITRATE INJECTION

Last updated on 2021-10-19 History
Report ID 146880
Drug Identification Number 02327813
Brand name GALLIUM (GA67) CITRATE INJECTION
Common or Proper name Gallium (Ga 67) Citrate injection
Company Name CURIUM CANADA INC
Market Status MARKETED
Active Ingredient(s) GALLIUM CITRATE GA 67
Strength(s) 74MBq
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 6 & 12 mCi
ATC code V09HX
ATC description
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-10-08
Actual start date 2021-10-08
Estimated end date 2021-10-15
Actual end date 2021-10-15
Shortage status Resolved
Updated date 2021-10-19
Company comments The most recent lot of Gallium Citrate Ga 67 Injection is outside our specifications for release. As a result, product will not be available for shipment Oct 8-14, 2021. The next lot is scheduled to release on Friday, Oct. 15. We apologize for an inconvenience caused by this issue.
Health Canada comments
Tier 3 Status No
Contact Address 2572 BOUL. DANIEL-JOHNSON
LAVAL, QUEBEC
CANADA H7T 2R3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-10-07 English Compare
v2 2021-10-07 French Compare
v3 2021-10-09 English Compare
v4 2021-10-19 English Compare
v5 2021-10-19 French Compare

Showing 1 to 5 of 5